Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload

Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic Carcinogenesis

(2009) Paola Dongiovanni et al.   AMERICAN JOURNAL OF PATHOLOGY

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer

(2009) Nicholas J. Osborne et al.   HEPATOLOGY

HaemochromatosisHFEgene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age

(2009) Zumin Shi et al.   INTERNATIONAL JOURNAL OF CANCER

The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis

(2008) Lyle C. Gurrin et al.   GASTROENTEROLOGY

Cancer as a Ferrotoxic Disease: Are We Getting Hard Stainless Evidence?

(2008) G. Edgren et al.   JNCI-Journal of the National Cancer Institute

Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors

(2008) Gustaf Edgren et al.   JNCI-Journal of the National Cancer Institute

Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial

(2008) L. R. Zacharski et al.   JNCI-Journal of the National Cancer Institute

Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

(2008) Katrina J. Allen et al.   NEW ENGLAND JOURNAL OF MEDICINE